Skip to main content
David Knopman, MD, Neurology, Rochester, MN

DavidSKnopmanMD

Neurology Rochester, MN

Neurodegenerative, Dementia & Geriatrics

Professor, Neurology, Mayo Medical School

Dr. Knopman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Knopman's full profile

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511

Summary

  • Dr. David Knopman is a neurologist at the Mayo Clinic, Rochester. He received his medical degree from University of Minnesota Medical School and has been in practice 42 years. He specializes in neurodegenerative and dementia & geriatrics.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Neurology, 1976 - 1979
  • Hennepin Healthcare
    Hennepin HealthcareInternship, Transitional Year, 1975 - 1976
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1975
  • Dartmouth College
    Dartmouth CollegeA.B., Biology, 1972

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1978 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Phi Beta Kappa Honor Society 1972
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Initial Β-amyloid Levels with Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment  
    David S Knopman, Bradley F Boeve, Ronald C Petersen, Clifford R Jack, JAMA Neurology
  • Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated with MAPT, GRN, and C9orf72 Pathogenic Variants  
    Nupur Ghoshal, Neill R Graff-Radford, David S Knopman, Zbigniew K Wszolek, Joel H Kramer, Bradley F Boeve, Howard J Rosen, JAMA Network Open
  • Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia  
    Mary M Machulda, Ronald C Petersen, David S Knopman, Yonas E Geda, Val J Lowe, Journal of the American Geriatrics Society
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Tdp-43 influences cognition, memory loss and hippocampal atrophy in Alzheimer's disease.
    Josephs K, Whitwell J, Weigand S, Murray M, Tosakulwong N, Liesinger A, Petrucelli L, Knopman D, Boeve B, Ivnik R, Smith G, Jack C, Parisi J, Petersen R, Dickson D, J Neuropathol Exp Neurol, 6/1/2014
  • Antemortem characterization of a kindred carrying the non-coding GGGGCC hexanucleotide repeat expansion in C9ORF72.
    Adeli A, Boeve B, DeJesus-Hernandez M, Baker M, Rutherford N, Knopman D, Ivnik R, Fields J, Petersen R, Rademakers R, Neurology, 4/1/2012
  • Characterization of the neuropsychiatric features associated with mutations in C9ORF72'MAPT and PGRN.
    Adeli A, Geda Y, Boeve B, Graff-Radford N, DeJesus-Hernandez M, Knopman D, Josephs K, Pedraza O, Rush B, Fields J, Rutherford N, Baker M, Smith G, Ivnik R, Pankratz V,..., Neurology, 4/1/2012
  • Join now to see all

Lectures

  • Alzheimers Disease 
    Curitiba, Brazil - 4/1/2004
  • Symptoms of Dementia 
    University of Colorado - 3/1/2004
  • 7th International Conference on Alzheimer's Disease 
    7/1/2000
  • Join now to see all

Press Mentions

  • Your Brain in Your 40s
    Your Brain in Your 40sNovember 23rd, 2024
  • Hearing Loss Tied to Cognitive Decline, Even with Hearing Aid Use
    Hearing Loss Tied to Cognitive Decline, Even with Hearing Aid UseOctober 8th, 2024
  • Alzheimer’s Drugs Are Arriving, but They Won’t Be Risk Free
    Alzheimer’s Drugs Are Arriving, but They Won’t Be Risk FreeMay 23rd, 2023
  • Join now to see all

Grant Support

  • Validating The New Criteria For Preclinical Alzheimer'S DiseaseNational Institute On Aging2012
  • Frontotemporal Degeneration: A Basis For Clinical TrialsNational Institute On Aging2004–2006
  • Frontotemporal Degeneration: A Basis For Clinical TrialsNational Institute On Aging2003
  • Epidemiology Of Alzheimer Disease In A Total PopulationNational Institute On Aging1992–1994
  • Scientific Evaluation And PlanningNational Institute Of Mental Health1991–1994